非维生素K 拮抗剂口服抗凝药治疗房颤的新进展
杨洁， 王晓明 - 心脏杂志, 2019 - heartj.cn
… Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights
from ENGAGE AF-TIMI 48[J]. Eur Heart J Acute Cardiovasc Care, 2019, 8(2): 176 – 185. …
from ENGAGE AF-TIMI 48[J]. Eur Heart J Acute Cardiovasc Care, 2019, 8(2): 176 – 185. …
[HTML][HTML] 老年患者抗凝药物使用进展
李文欣， 李兴升 - Advances in Clinical Medicine, 2021 - hanspub.org
… number of elderly people over 65 years old, and elderly patients often have atrial fibrillation,
… 对于老年房颤患者,ENGAGE AF-TIMI 48第3期试验中表示每天服用一次艾多沙班(高剂量60…
… 对于老年房颤患者,ENGAGE AF-TIMI 48第3期试验中表示每天服用一次艾多沙班(高剂量60…
在癌症和非癌症患者中非维生素K 拮抗剂口服抗凝药的相对效益分析: 随机对照试验的Meta 分析
王晨曦， 杨萍萍， 李忠城， 邬涛， 吴清华 - 临床心血管病杂志, 2020 - lcxxg.whuhzzs.com
… Efficacy and safety of Edoxaban in patients with active alignancy and atrial fibrillation:analysis
of the ENGAGE AF-TIMI 48 Trial[J].J Am Heart Assoc,2018,7(16):e008987. …
of the ENGAGE AF-TIMI 48 Trial[J].J Am Heart Assoc,2018,7(16):e008987. …
心房颤动患者使用新型口服抗凝药有效性和安全性的网状Meta 分析
霍礼超， 李梦丽， 宋明惠， 张彦霞， 薛鹏龙， 乔成栋 - 中国全科医学, 2019 - chinagp.net
… after cardioversion for atrial fibrillation:insights from the ARISTOTLE trial(apixaban for …
efficacy and safety of edoxaban compared with warfarin—insights from the engage AF-TIMI 48 …
efficacy and safety of edoxaban compared with warfarin—insights from the engage AF-TIMI 48 …
新型口服抗凝药物在非瓣膜性心房颤动患者中的应用及挑战
刘岳， 任怡荣， 朱火兰， 汪芳 - 中国全科医学, 2020 - chinagp.net
… in atrial fibrillation,it is found that NOACs has the advantages of good efficacy and high
safety,… Edoxaban versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2013,369(22):…
safety,… Edoxaban versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2013,369(22):…
口服抗凝剂在非瓣膜性房颤伴慢性肾功能不全患者中的应用进展
李欣， 刘璐， 柳志红， 赵智慧， 罗勤， 赵青 - 协和医学杂志, 2022 - xhyxzz.pumch.cn
… of stroke in patients with atrial fibrillation. However, patients with atrial fibrillation and chronic
… anticoagulants are non-inferior to warfarin in efficacy and safety. They don't require routine …
… anticoagulants are non-inferior to warfarin in efficacy and safety. They don't require routine …
[PDF][PDF] 艾多沙班片致严重上消化道出血2 例
李燕， 陈龙， 周根青， 周佳纯 - 医药导报, 2023 - yydbzz.com
… 班导致上消化道出血 的案例报道ꎮ ENGAGE AF-TIMI 48 试验 … with factor Xa next
generation in atrial fibrillation-… -dose edoxaban in very elderly patients with atrial fibrillation[…
generation in atrial fibrillation-… -dose edoxaban in very elderly patients with atrial fibrillation[…
[HTML][HTML] 新型直接口服抗凝药物与胃肠道出血的研究进展
钱阳阳， 廖专， 李兆申 - 第二军医大学学报, 2017 - html.rhhz.net
… of thrombotic stroke in patients with nonvalvular atrial fibrillation and for treatment of venous
… 针对依度沙班的临床试验ENGAGE AF-TIMI 48显示,依度沙班剂量的增加可使MGIB的发生风险…
… 针对依度沙班的临床试验ENGAGE AF-TIMI 48显示,依度沙班剂量的增加可使MGIB的发生风险…
[PDF][PDF] 肾功能衰竭患者心房颤动的抗凝治疗进展
王凯， 刘元生， 高伟波， 朱继红 - 中国血液净化, 2018 - cjbp.org.cn
… older adults with atrial fibrillation starting warfarin treatment: population based observational
study… Impact of renal function on out comes with edoxaban in the ENGAGE AF-TIMI 48 Trial[J…
study… Impact of renal function on out comes with edoxaban in the ENGAGE AF-TIMI 48 Trial[J…
[PDF][PDF] 老年人心房颤动血栓防控中新型口服抗凝药物的应用与比较
骆雷鸣 - 实用老年医学, 2016 - sylnyx.com
… warfarin in older and younger patients with atrial fibrillation: an a⁃ … Efficacy and Safety of
Edoxaban for the Man⁃ agement of Elderly Patients With Atrial Fibrillation: Engage AF⁃TIMI 48 …
Edoxaban for the Man⁃ agement of Elderly Patients With Atrial Fibrillation: Engage AF⁃TIMI 48 …